Human Osteopontin/OPN Biologically Active Protein Summary
Description |
A biologically active protein with a C-terminal 6-His tag corresponding to amino acids Ile17 – Asn300 to SPP1.
Source: Mouse myeloma cell line, NS0 |
Preparation Method |
Lyophilized from a 0.2 um filtered solution in PBS.
|
Details of Functionality |
Measured by the ability of the immobilized protein to support the adhesion of HEK293 human embryonic kidney cells. Recombinant Human (rh) Osteopontin/OPN immobilized at 1 ug/mL, 100 uL/well, will mediate the adhesion of added 293 cells >30% (1 x 105 cells/well). Recombinant Human Coagulation Factor II/Thrombin (Catalog # 1473-SE) proteolytic treatment of this rhOsteopontin/his can increase HEK293 cell adhesion by about 5-fold.
|
Protein/Peptide Type |
Biologically Active Protein
|
Gene |
SPP1
|
Endotoxin Note |
<0.10 EU per 1 ug of the protein by the LAL method.
|
Applications/Dilutions
Theoretical MW |
32.9 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
Packaging, Storage & Formulations
Storage |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
|
Concentration |
LYOPH
|
Reconstitution Instructions |
Reconstitute with 0.1 mg/ml in sterilized PBS to desired concentration.
|
Notes
Alternate Names for Human Osteopontin/OPN Biologically Active Protein
- BNSP
- Bone sialoprotein 1
- Eta-1
- MGC110940
- Nephropontin
- OPN
- Osteopontin
- secreted phosphoprotein 1bone sialoprotein I, early T-lymphocyteactivation 1)
- secreted phosphoprotein-1 (osteopontin, bone sialoprotein)
- Spp1
- SPP-1
- SPP1/CALPHA1 fusion
- Urinary stone protein
- uropontin